COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma

Gaitzsch E, Passerini V, Khatamzas E, Strobl CD, Muenchhoff M, Scherer C, Osterman A, Heide M, Reischer A, Subklewe M, Leutbecher A, Tast B, Ruhle A, Weiglein T, Stecher SS, Stemmler HJ, Dreyling M, Girl P, Georgi E, Woelfel R, Mateyka L, D'Ippolito E, Schober K, Busch DH, Kager J, Spinner CD, Treiber M, Rasch S, Lahmer T, Iakoubov R, Schneider J, Protzer U, Winter C, Ruland J, Quante M, Keppler OT, Von Bergwelt-Baildon M, Hellmuth J, Weigert O (2021)

Publication Status: Published

Publication Type: Journal article, Original article

Publication year: 2021

Journal

HemaSphere Lippincott, Williams & Wilkins

Publisher: Wolters Kluwer Health

DOI: 10.1097/HS9.0000000000000603

Authors with CRIS profile

Kilian Schober

Involved external institutions

Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Technische Universität München (TUM) DE Germany (DE) Institut für Mikrobiologie der Bundeswehr / The Bundeswehr Institute of Microbiology (IMB) - InstMikroBioBw DE Germany (DE) Deutsches Zentrum für Infektionsforschung (DZIF) DE Germany (DE) Deutsches Krebsforschungszentrum (DKFZ) DE Germany (DE)

How to cite

APA:

Gaitzsch, E., Passerini, V., Khatamzas, E., Strobl, C.D., Muenchhoff, M., Scherer, C.,... Weigert, O. (2021). COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma. HemaSphere. https://doi.org/10.1097/HS9.0000000000000603

MLA:

Gaitzsch, Erik, et al. "COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma." HemaSphere (2021).

BibTeX: Download